At week 12, IL-17A levels were significantly higher in the FMT-CRC group compared to the positive control, reinforcing the hypothesis that CRC-derived microbiota contributes to a pro-inflammatory tumor microenvironment. This evidence concerns the gene IL17A and colorectal carcinoma.